Utilisation des PRP en traumatologie sportive en 2019. Recommandations professionnelles de la Société française de traumatologie du sport

Bouvard, Marc; Kaux, Jean-François; Dalmais, Etienne; Proulle, Valérie; Lamontagne, Martin; Frey, Alain

doi:10.1016/j.jts.2019.12.005

Article (Scientific journals)

Utilisation des PRP en traumatologie sportive en 2019. Recommandations professionnelles de la Société française de traumatologie du sport

Bouvard, Marc; Kaux, Jean-François; Dalmais, Etienne et al.

2020 • In Journal de Traumatologie du Sport, 37 (1), p. 26-35

Peer reviewed

Permalink
https://hdl.handle.net/2268/245784

DOI
10.1016/j.jts.2019.12.005

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

1-s2.0-S0762915X19301287-main.pdf

Publisher postprint (1.04 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[fr] L'apparition des plasmas riches en plaquettes dans l'arsenal thérapeutique au début des années 2000 a été suivie par un développement exponentiel de son usage, notamment en pathologie sportive. La Société française de traumatologie du sport a souhaité faire une mise au point des connaissances sur ce sujet et des recommandations pour un bon usage. La composition des PRP utilisés en traumatologie sportive est très hétérogène et trop souvent opaque. La conséquence est l'entretien d'une confusion et un manque de clarté dans le débat scientifique quant à l'intérêt de cette technique chez les sportifs. La définition des PRP est rappelée : couche profonde du plasma riche en plaquettes (entre 6 et 9 105 PQ/mL) après centrifugation qui ne doit contenir aucune autre cellule dans toute la mesure du possible (facteurs de la coagulation non activés, leuco- cytes < 1 %, érythrocytes < 1 %). À ce jour, l'injection de PRP dans les douleurs des lésions cartilagineuses apporte une amélioration égale ou supérieure à l'acide hyaluronique sur un grand nombre d'études de haut niveau de preuve. Le PRP est une option thérapeutique intéressante pour les tendinopathies patellaires et, dans une moindre mesure, pour les tendinopathies des épicondyliens latéraux, de l'aponévrose plantaire, les enthésopathies proximales des ischiojam- biers, les tendinopathies du moyen glutéal ou de la coiffe des rotateurs. Concernant toutes les autres localisations, il n'existe pas ou peu de données. L'utilisation de PRP en pathologie du sport doit suivre une démarche diagnostique exhaustive et rigoureuse, la plupart du temps multidisci- plinaire et appliquer des règles d'asepsie strictes. Dans la grande majorité des cas, l'injection doit bénéficier d'un guidage par échographie. De futures études de haut niveau de preuve sont encore nécessaires afin de mieux définir les bonnes indications et les meilleures modalités d'injection.
[en] Since its advent as part of the therapeutic armamentarium early in the 2000s, platelet-rich plasma (PRP) products have been widely used in sports pathology. The French Society of Sports Traumatology has published guidelines for good clinical practices when using PRP. PRP products used in sports medicine have various compositions that are not always explicitly described. There is thus a certain confusion in the scientific debate on their usefulness for athletes. PRP can be defined as a deep layer of plasma with a high platelet count (6 to 9 105 PQ/ml) after centrifugation and as far as possible no cells (non-activated coagulation factors, white cells < 1%, red cells < 1%). According to large-scale studies with a high level of proof, PRP injections provide relief for cartilage injury-related pain that is as good as or better than that obtained with hyaluronic acid. PRP is an attractive therapeutic option for patellar tendinopathy and to a lesser degree for certain other localizations: lateral epicondyles, plantar aponeurosis,hamstring proximal enthesis, gluteus medius, rotator cuff. Data are not available for other localizations. A rigorous exhaustive diagnostic approach is required for using PRP in sports medicine. A multidisciplinary concertation is usually needed, together with strict asepsis. Ultrasound guidance is generally recommended. Further studies with a high level of proof are still necessary to better define appropriate indications and injection modalities.

Disciplines :

Laboratory medicine & medical technology

Author, co-author :

Bouvard, Marc

Kaux, Jean-François ; Université de Liège - ULiège > Département des sciences de la motricité > Médecine physique, réadaptation et traumatologie du sport

Dalmais, Etienne

Proulle, Valérie

Lamontagne, Martin

Frey, Alain

Language :

French

Title :

Utilisation des PRP en traumatologie sportive en 2019. Recommandations professionnelles de la Société française de traumatologie du sport

Alternative titles :

[en] Use of platelet-rich plasma in sports medicine in 2019. Guidelines from the French Society of Sports Traumatology

Publication date :

March 2020

Journal title :

Journal de Traumatologie du Sport

ISSN :

0762-915X

eISSN :

1773-0465

Publisher :

Elsevier Masson, Paris, France

Volume :

Issue :

Pages :

26-35

Peer reviewed :

Peer reviewed

Available on ORBi :

since 09 March 2020

Statistics

Number of views

96 (18 by ULiège)

Number of downloads

32 (23 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Anitua, E., Sánchez, M., Orive, G., Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev 62:7–8 (2010), 741–752.
Anitua, E., Sánchez, M., Orive, G., The importance of understanding what is platelet-rich growth factor (PRGF) and what is not. J Shoulder Elbow Surg 20:1 (2011), e23–e24.
Kaux, J.F., Croisier, J.L., Léonard, P., Le Goff, C., Crielaard, J.M., Exuberant inflammatory reaction as a side effect of platelet-rich plasma injection in treating one case of tendinopathy. Clin J Sport Med 24:2 (2014), 150–152.
Kaux, J.F., Bouvard, M., Lecut, C., Oury, C., Gothot, A., Sanchez, M., et al. Reflections about the optimisation of the treatment of tendinopathies with PRP. Muscles Ligaments Tendons J 5:1 (2015), 1–4.
Scully, D., Naseem, K.M., Matsakas, A., Platelet biology in regenerative medicine of skeletal muscle. Acta Physiol (Oxf), 223(3), 2018, e1307.
Amin, I., Gellhorn, A.C., Platelet-rich plasma use in musculoskeletal disorders: are the factors important in standardization well understood?. Phys Med Rehabil Clin N Am 30:2 (2019), 439–449.
DeLong, J.M., Russell, R.P., Mazzocca, A.D., Platelet-rich plasma: the PAW classification system. Arthroscopy 28 (2012), 998–1009.
Dohan Ehrenfest, D.M., Bielecki, T., Mishra, A., et al. In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Curr Pharm Biotechnol 13:7 (2012), 1131–1137.
Mautner, K., Malanga, G.A., Smith, J., et al. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM R 7:4 Suppl. (2015), S53–S59.
Magalon, J., Chateau, A.L., Bertrand, B., et al. DEPAclassification: a proposal for standardizing PRP use and retrospective application of available devices. BMJ Open Sport Exerc Med 2:1 (2016), 1–5.
Lana, J.F.S.D., Purita, J., Paulus, C., et al. Contributions for classification of platelet rich plasma — proposal of a new classification: MARSPILL. Regen Med 12:5 (2017), 565–574.
Kia, C., Baldino, J., Bell, R., et al. Platelet-rich plasma: review of current literature on its use for tendon and ligament pathology. Curr Rev Musculoskelet Med 11 (2018), 566–572.
Kaux, J.F., Drion, P., Croisier, J.L., et al. Tendinopathies and platelet-rich plasma (PRP): from pre-clinical experiments to therapeutic use. J Stem Cells Regen Med, 11(1), 2015, 7.
Lin, M.-T., Chiang, C.-F., et al. Comparative effectiveness of injection therapies in rotator cuff tendinopathy: a systematic review, pairwise and network meta-analysis of randomized controlled trials. Arch Phys Med Rehabil 100 (2018), 336–349.
Franchini, M., Cruciani, M., Mengoli, C., et al. Efficacy of platelet-rich plasma as conservative treatment in orthopaedics: a systematic review and meta-analysis. Blood Transfus 16 (2018), 502–513.
Everts, P.A., Malanga, G.A., Paul, R.V., Review Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies. A review. Regen Ther 11 (2019), 56–64.
Chen, X., Jones, I.A., Park, C., et al. The efficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta-analysis with bias assessment. Am J Sports Med 46:8 (2018), 2020–2032.
Dupley, L., Charalambous, C.P., Platelet rich plasma injections as a treatment for refractory patellar tendinosis: a metaanalysis of randomised trials. Knee Surg Relat Res 29:3 (2017), 165–171.
Erroi, D., Sigona, M., Suarez, T., Trischitta, D., Pavan, A., Vulpiani, M.C., et al. Conservative treatment for Insertional Achilles Tendinopathy: platelet-rich plasma and focused shock waves. A retrospective study. Muscles Ligaments Tendons J 1 (2017), 98–106.
Ploug Boesen, A., Hansen, R., Ilum Boesen, M., et al. Effect of high-volume injection, platelet-rich plasma, and sham treatment in chronic midportion achilles tendinopathy: a randomized double-blinded prospective study. Am J Sports Med 45:9 (2017), 2034–2043.
Miller, L.E., Parrish, W.R., Roides, B., Bhattacharyya, S., Efficacy of platelet-rich plasma injections for symptomatic tendinopathy: systematic review and meta-analysis of randomised injection-controlled trials. BMJ Open Sport Exerc Med, 3, 2017, e000237.
Merolla, G., Dellabiancia, F., Ricc, A., et al. Arthroscopic debridement versus platelet-rich plasma injection: a prospective, randomized, comparative study of chronic lateral epicondylitis with a nearly 2-year follow up. Arthroscopy 33:7 (2017), 1320–1329.
Mi, B., Liu, G., Zhou, W., Lv, H., Liu, Y., Wu, Q., et al. Platelet rich plasma versus steroid on lateral epicondylitis: meta-analysis of randomized clinical trials. Phys Sports Med 45:2 (2017), 97–104.
Pereira Palacio, E., Ramos Schiavetti, R., Kanematsu, M., et al. Effects of platelet-rich plasma on lateral epicondylitis of the elbow: prospective randomized controlled trial. Rev Bras Ortop 51:1 (2016), 90–95.
Salini, V., Vanni, D., Pantalone, A., Abate, M., Platelet rich plasma therapy in non-insertional achilles tendinopathy: the efficacy is reduced in 60-years old people compared to young and middle-age individuals. Frontiers Aging Neurosci, 7, 2015 [Article 228].
Kaux, J.F., Croisier, J.L., Bruyere, O., et al. One injection of platelet-rich plasma associated to a submaximal eccentric protocol to treat chronic jumper's knee. J Sports Med Physical Fitness 5:55 (2015), 953–961.
Kaux, J.F., Croisier, J.L., Forthomme, B., et al. Using platelet-rich plasma to treat jumper's knees: exploring the effect of a second closely-timed infiltration. J Sci Med Sport 19 (2015), 200–204.
Milants, C., Bruyère, O., Kaux, J.F., Responders to platelet-rich plasma in osteoarthritis: a technical analysis. Biomed Res Int, 2017, 2017, 7538604, 10.1155/2017/7538604 [Epub 2017 Aug 20].
Levy, G.M., Lucas, P., Hope, N., Efficacy of a platelet-rich plasma injection for the treatment of proximal hamstring tendinopathy: a pilot study. J Sci Med Sport 13 (2019), 247–252.
Fitzpatrick, J., Bulsara, M.K., O'Donnell, J., Hao Zheng, M., Leucocyte-rich platelet-rich plasma treatment of gluteus medius and minimus tendinopathy: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med 47:5 (2019), 1130–1137.
Fitzpatrick, J., Bulsara, M.K., O'Donnell, J., et al. The effectiveness of platelet-rich plasma injections in gluteal tendinopathy: a randomized, double-blind controlled trial comparing a single platelet-rich plasma injection with a single corticosteroid injection. Am J Sports Med 46:4 (2018), 933–939.
Guelfi, M., Pantalone, A., Vanni, D., et al. Long-term beneficial effects of platelet-rich plasma for non-insertional Achilles tendinopathy. Foot Ankle Surg 21 (2014), 178–181.
Hyunchul Jo, C., Yeon Lee, S., Sup Yoon, K., et al. Allogenic pure platelet-rich plasma therapy for rotator cuff disease: a bench and bed study. Am J Sports Med 46:13 (2018), 3142–3154.
Le, A.D.K., Enweze, L., DeBaun, M.R., Dragoo, J.L., Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med 11 (2018), 624–634.
Filardo, F., Kon, E., Di Matteo, B., et al. Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years. Blood Transfus 12 (2014), 533–540.
Patel, S., Dhillon, M.S., Aggarwal, S., Marwaha, N., Jain, A., Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 41:2 (2013), 356–364.
Andriolo, L., Altamura, S.A., Reale, D., et al. Nonsurgical treatments of patellar tendinopathy: multiple injections of platelet-rich plasma are a suitable option: a systematic review and meta-analysis. Am J Sports Med 47:4 (2018), 1001–1018.
Balasubramaniam, U., Dissanayake, R., Annabell, L., Efficacy of platelet-rich plasma injections in pain associated with chronic tendinopathy: a systematic review. Physician Sports Med 43:3 (2015), 253–261.
Zayni, R., Thaunat, M., Fayard, J.M., et al. Platelet-rich plasma as a treatment for chronic patellar tendinopathy: comparison of a single versus two consecutive injections. Muscles Ligaments Tendons J 5:2 (2015), 92–98.
de Vos, R.J., Windt, J., Weir, A., Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review. Br J Sports Med 48 (2014), 952–956.
Reurink, G., Goudswaard, G.J., Moen, M.H., Weir, A., Verhaar, J.A., Tol, J.L., Myotoxicity of injections for acute muscle injuries: a systematic review. Sports Med 44:7 (2014), 943–956.
Görmeli, G., Görmeli, C.A., Ataoglu, B., Çolak, C., Aslantürk, O., Ertem, K., Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc 25:3 (2017), 958–965.
Sussman, W.I., Mautner, K., Malanga, G., The role of rehabilitation after regenerative and orthobiologic procedures for the treatment of tendinopathy: a systematic review. Regen Med 13:2 (2018), 249–263.
Mautner, K., Malanga, G., Colberg, R., Optimization of ingredients, procedures and rehabilitation for platelet-rich plasma injections for chronic tendinopathy. Pain Manag 1:6 (2011), 523–532.
Finnoff, J.T., Fowler, S.P., Lai, J.K., Santrach, P.J., Willis, E.A., Sayeed, Y.A., et al. Treatment of chronic tendinopathy with ultrasound-guided needle tenotomy and platelet-rich plasma injection. PMR 3:10 (2011), 900–911.
Van Ark, M., van den Akker-Scheek, I., Meijer, L.T., Zwerver, J., An exercise-based physical therapy program for patients with patellar tendinopathy after platelet-rich plasma injection. Phys Ther Sport 14:2 (2013), 124–130.
Kilincoglu, Yeter, A., Servet, E., Kangal, M., Yildirim, M., Short term results comparison of intraarticular platelet-rich plasma (PRP) and hyaluronic acid (HA) applications in early stage of knee osteoarthritis. Int J Clin Exp Med 8:10 (2015), 18807–18812.
Filardo, G., Kon, E., Di Martino, A., Di Matteo, B., Merli, M.L., Cenacchi, A., et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord, 13, 2012, 229.
Mei-Dan, O., Carmont, M.R., Laver, L., Mann, G., Maffulli, N., Nyska, M., Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 40:3 (2012), 534–541.
Sánchez, M., Guadilla, J., Fiz, N., Andia, I., Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology (Oxford) 51:1 (2012), 144–150.
Cerza, F., Carnì, S., Carcangiu, A., Di Vavo, I., Schiavilla, V., Pecora, A., et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 40:12 (2012), 2822–2827.
Say, F., Gürler, D., Yener, K., Bülbül, M., Malkoc, M., Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chir Orthop Traumatol Cech 80:4 (2013), 278–283.
Raeissadat, S.A., Rayegani, S.M., Hassanabadi, H., Fathi, M., Ghorbani, E., Babaee, M., et al. Knee osteoarthritis injection choices: platelet-rich plasma (PRP) versus hyaluronic acid (A one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskelet Disord 8 (2015), 1–8.
Dallari, D., Stagni, C., Rani, N., Sabbioni, G., Pelotti, P., Torricelli, P., et al. Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a randomized controlled study. Am J Sports Med 44:3 (2016), 664–671.
Kanchanatawan, W., Arirachakaran, A., Chaijenkij, K., Prasathaporn, N., Boonard, M., Piyapittayanun, P., et al. Sort-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc 24:5 (2016), 1665–1677.
Cole, B.J., Karas, V., Hussey, K., Pilz, K., Fortier, L.A., Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med 45:2 (2017), 339–346.
Shen, L., Yuan, T., Chen, S., Xie, X., Zhang, C., The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res, 12(1), 2017, 16.
Meheux, C.J., McCulloch, P.C., Lintner, D.M., Varner, K.E., Harris, J.D., Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy 32:3 (2016), 495–505.
Filardo, G., Di Matteo, B., Di Martino, A., Merli, M.L., Cenacchi, A., Fornasari, P., et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med 43:7 (2015), 1575–1582.
Laver, L., Marom, N., Dnyanesh, L., Mei-Dan, O., Espregueira-Mendes, J., Gobbi, A., PRP for degenerative cartilage disease: a systematic review of clinical studies. Cartilage 8:4 (2017), 341–364.
Lisi, C., Perotti, C., Scudeller, L., Sammarchi, L., Dametti, F., Musella, V., et al. Treatment of knee osteoarthritis: platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial. Clin Rehabil 32:3 (2018), 330–339.
Saturveithan, C., Premganesh, G., Fakhrizzaki, S., Mahathir, M., Karuna, K., Rauf, K., et al. Intra-articular hyaluronic acid (HA) and platelet rich plasma (PRP) injection versus hyaluronic acid (HA) injection alone in patients with grade III and IV knee osteoarthritis (OA): a retrospective study on functional outcome. Malays Orthop J 10:2 (2016), 35–40.
Görmeli, G., Karakaplan, M., Görmeli, C.A., Sarıkaya, B., Elmalı, N., Ersoy, Y., Clinical effects of platelet-rich plasma and hyaluronic acid as an additional therapy for talar osteochondral lesions treated with microfracture surgery: a prospective randomized clinical trial. Foot Ankle Int 36:8 (2015), 891–900.
Vannabouathong, C., Del Fabbro, G., Sales, B., Smith, C., Li, C.S., Yardley, D., et al. Intra-articular injections in the treatment of symptoms from ankle arthritis: a systematic review. Foot Ankle Int 39:10 (2018), 1141–1150.
Di, Y., Han, C., Zhao, L., Ren, Y., Is local platelet-rich plasma injection clinically superior to hyaluronic acid for treatment of knee osteoarthritis? A systematic review of randomized controlled trials. Arthritis Res Ther, 20(1), 2018, 128.
Buendía-López, D., Medina-Quirós, M., Fernández-Villacañas Marín, M.Á., Clinical and radiographic comparison of a single LP-PRP injection, a single hyaluronic acid injection and daily NSAID administration with a 52-week follow-up: a randomized controlled trial. J Orthop Traumatol, 19(1), 2018, 3.
Louis, M.L., Magalon, J., Jouve, E., Bornet, C.E., Mattei, J.C., Chagnaud, C., et al. Growth factors levels determine efficacy of platelets rich plasma injection in knee osteoarthritis: a randomized double blind noninferiority trial compared with viscosupplementation. Arthroscopy 34:5 (2018), 1530–1540.
Sánchez, M., Delgado, D., Pompei, O., Pérez, J.C., Sánchez, P., Garate, A., et al. Treating severe knee osteoarthritis with combination of intra-osseous and intra-articular infiltrations of platelet-rich plasma: an observational study. Cartilage 10:2 (2019), 245–253.
Doria, C., Mosele, G.R., Caggiari, G., Puddu, L., Ciurlia, E., Treatment of early hip osteoarthritis: ultrasound-guided platelet rich plasma versus hyaluronic acid injections in a randomized clinical trial. Joints 5:3 (2017), 152–155.
Altman, R., Fredericson, M., Bhattacharyya, S.K., Bisson, B., Abbott, T., Yadalam, S., et al. Association between hyaluronic acid injections and time-to-total knee replacement surgery. J Knee Surg 29:7 (2016), 564–570.
Waddell, D.D., Joseph, B., Delayed total knee replacement with Hylan G-F 20. J Knee Surg 29:2 (2016), 159–168.
Fiz, N., Pérez, J.C., Guadilla, J., Garate, A., Sánchez, P., Padilla, S., et al. Intraosseous infiltration of platelet-rich plasma for severe hip osteoarthritis. Arthrosc Tech 6:3 (2017), e821–e825.
Sun, Y., Feng, Y., Zhang, C.Q., Chen, S.B., Cheng, X.G., The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 34:4 (2010), 589–597.
Kon, E., Buda, R., Filardo, G., Di Martino, A., Timoncini, A., Cenacchi, A., et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 18:4 (2010), 472–479.
Filardo, G., Kon, E., Buda, R., Timoncini, A., Di Martino, A., Cenacchi, A., et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 19:4 (2011), 528–535.
Bendinelli, P., Matteucci, E., Dogliotti, G., Corsi, M.M., Banfi, G., Maroni, P., et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. J Cell Physiol 225:3 (2010), 757–766.
Milano, G., Sanna Passino, E., Deriu, L., Careddu, G., Manunta, L., Manunta, A., et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model. Osteoarthritis Cartilage 18:7 (2010), 971–980.
Papalia, R., Diaz Balzani, L., Torre, G., Tirindelli, M.C., Nobile, C., Maffulli, N., et al. Intraoperative application Platelet rich fibrin, postoperative injections OF PRP or microfracture only for osteochondral lesions of the knee: a five-year retrospective evaluation. J Biol Regul Homeost Agents 30:4 Suppl. 1 (2016), 41–49.
Bengtsson, H., Ekstrand, J., Waldén, M., et al. Muscle injury rate in professional football is higher in matches played within 5 days since the previous match: a 14-year prospective study with more than 130,000 match observations. Br J Sports Med 52 (2018), 1116–1122.
Edouard, P., Branco, P., Alonso, J.-M., Muscle injury is the principal injury type and hamstring muscle injury is the first injury diagnosis during top-level international athletics championships between 2007 and 2015. Br J Sports Med 50:10 (2016), 619–630.
Rossi, L.A., Molina Rómoli, A.R., Bertona Altieri, B.A., et al. Does platelet-rich plasma decrease time to return to sports in acute muscle tear? A randomized controlled trial. Knee Surg Sports Traumatol Arthrosc, 25, 2017, 3319.
Hamid, M.S.A., Ali, M.R.M., Ashril, Y., et al. Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial. Am J Sports Med 42:10 (2014), 2410–2418.
Hotfiel, T., Seil, R., Bily, W., et al. Nonoperative treatment of muscle injuries — recommendations from the GOTS expert meeting. J Exp Orthop, 5, 2018, 24.
Bisciotti, G.N., Volpi, P., Amato, M., et al. Italian consensus conference on guidelines for conservative treatment on lower limb muscle injuries in athlete. BMJ Open Sport Exerc Med, 4, 2018, 1.
Van Dyk, N., Behan, F.P., Whiteley, R., Including the Nordic hamstring exercise in injury prevention programmes halves the rate of hamstring injuries: a systematic review and meta-analysis of 8459 athletes. Br J Sports Med 21 (2019), 1362–1370.
Wright-Carpenter, T., Opolon, P., Appell, H.J., Meijer, H., Wehling, P., Mir, L.M., Treatment of muscle injuries by local administration of autologous conditioned serum: animal experiments using a muscle contusion model. Int J Sports Med 25:8 (2004), 582–587.
Hammond, J.W., Hinton, R.Y., Curl, L.A., Muriel, J.M., Lovering, R.M., Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med 37:6 (2009), 1135–1142.
Reurink, G., Goudswaard, G.J., Moen, M.H., et al. Rationale, secondary outcome scores and 1-year follow-up of a randomised trial of platelet-rich plasma injections in acute hamstring muscle injury: the Dutch Hamstring Injection Therapy study. Br J Sports Med 49 (2015), 1206–1212.
Hamilton, B., Tol, J.L., Almusa, E., et al. Br J Sports Med 49 (2015), 943–950.
Guillodo, Y., Madouas, G., Simon, T., Le Dauphin, H., Saraux, A., Platelet-rich plasma (PRP) treatment of sports-related severe acute hamstring injuries. Muscles Ligaments Tendons J 5:4 (2015), 284–288.
Bubnov, R., Yevseenko, V., Semeniv, I., Ultrasound guided injections of Platelets Rich Plasma for muscle injury in professional athletes. Comparative study. Med Ultrason 15:2 (2013), 101–105.
Martinez-Zapata, M.J., Orozco, L., Balius, R., et al. Efficacy of autologous platelet-rich plasma for the treatment of muscle rupture with haematoma: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Blood Transfus 14:2 (2016), 245–254.
Magalon, J., Bausset, O., Serratrice, N., et al. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy 30 (2014), 629–638.
Klatte-Schulz, F., Schmidt, T., Uckert, M., et al. Comparative analysis of different platelet lysates and platelet rich preparations to stimulate tendon cell biology: an in vitro study. Int J Mol Sci, 19, 2018, 212.
Henning, R.J., Khan, A., Jimenez, E., Chitosan hydrogels significantly limit left ventricular infarction and remodeling and preserve myocardial contractility. J Surg Res 201:2 (2016), 490–497.
Vaudreuil, N., Henrikson, K., Pohl, P., et al. Photopolymerizable biogel scaffold seeded with mesenchymal stem cells: safety and efficacy evaluation of novel treatment for intervertebral disc degeneration. J Orthop Res 37:6 (2019), 1451–1459.
Farkash, U., Avisar, E., Volk, I., First clinical experience with a new injectable recombinant human collagen scaffold combined with autologous platelet-rich plasma for the treatment of lateral epicondylar tendinopathy (tennis elbow). J Shoulder Elbow Surg 28:3 (2019), 503–509.
Chang, N.J., Erdenekhuyag, Y., Chou, P.H., et al. Therapeutic effects of the addition of platelet-rich plasma to bioimplants and early rehabilitation exercise on articular cartilage repair. Am J Sports Med 46:9 (2018), 2232–2241.
Gao, X., Gao, L., Groth, T., et al. Fabrication and properties of an injectable sodium alginate/PRP composite hydrogel as a potential cell carrier for cartilage repair. J Biomed Mater Res A 107:9 (2019), 2076–2087.
Laver, L., Carmont, M.R., McConkey, M.O., Palmanovich, E., Yaacobi, E., Mann, G., et al. Plasma rich in growth factors (PRGF) as a treatment for high ankle sprain in elite athletes: a randomized control trial. Knee Surg Sports Traumatol Arthrosc 23:11 (2015), 3383–3392.
Samra, D.J., Sman, A.D., Rae, K., Linklater, J., Refshauge, K.M., Hiller, C.E., Effectiveness of a single platelet-rich plasma injection to promote recovery in rugby players with ankle syndesmosis injury. BMJ Open Sport Exerc Med, 1(1), 2015 [E].
Everhart, J.S., Cavendish, P.A., Eikenberry, A., Magnussen, R.A., Kaeding, C.C., Flanigan, D.C., Platelet-rich plasma reduces failure risk for isolated meniscal repairs but provides no benefit for meniscal repairs with anterior cruciate ligament reconstruction. Am J Sports Med 47:8 (2019), 1789–1796.
Figueroa, D., Figueroa, F., Calvo, R., Vaisman, A., Ahumada, X., Arellano, S., Platelet-rich plasma use in anterior cruciate ligament surgery: systematic review of the literature 31:5 (2015), 981–988.